Evidence & regulatory context
- Mechanism
- Cell therapy; not a defined chemical entity, no ChEMBL record.
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseChemical/toxinC57BL/6FemaleIntracerebral implantation4 h (early) or 72 h (late) after injury
Model: Ibotenate-induced neonatal excitotoxic brain injury (cerebral palsy model)
Neurosphere-derived precursor implants reduced lesion size and improved memory after neonatal excitotoxic brain injury.
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.
